vandetanib

Trials studying vandetanib

• phase3Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatmentcompletedn=205
• phase3A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Canceractive not recruitingn=291
• phase4To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancercompletedn=81
• phase3An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancercompletedn=331
• phase2Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinomacompletedn=142
• phase2SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Canceractive not recruitingn=1,460
• phase3Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patientscompletedn=698
• —Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancercompletedn=31